Up-regulation of hypoxia-inducible factor 1α is an early event in prostate carcinogenesis

Cancer Detection and Prevention

Volumn 28, Issue 2, 2004, Pages 88-93

  Zhong, Hua ^a   Semenza, Gregg L ^b   Simons, Jonathan W ^a   De Marzo, Angelo M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; BPH; HG PIN; HIF 1; High grade PIN; Hypoxia inducible factor 1; IGF; Insulin like growth factor; PCA; PIN; Prostate; Prostatic adenocarcinoma; Prostatic intraepithelial neoplasia; Vascular endothelial growth factor; VEGF

Indexed keywords

DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; CHEMISTRY; HUMAN; MALE; PHYSIOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; UPREGULATION;

DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NUCLEAR PROTEINS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 1842426907     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2003.12.009     Document Type: Article

References (22)

1. Jemal A., Murray T., Samuels A.et al. Cancer statistics. CA Cancer J. Clin. 53:2003;5-26.
2. McNeal J.E., Bostwick D.G. Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Pathol. 17:1986;64-71.
3. Weinstein M.H., Epstein J.I. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum. Pathol. 24:1993;624-629.
4. DeMarzo A.M., Nelson W.G., Isaacs W.B.et al. Pathological and molecular aspects of prostate cancer. Lancet. 361:2003;955-964.
5. Brooks J.D., Weinstein M., Lin X.et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev. 7:1998;531-536.
6. Folkman J., Watson K., Ingber D.et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
7. Sinha A.A., Gleason D.F., Staley N.A.et al. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat. Rec. 241:1995;353-362.
8. Tennant M.K., Thrasher J.B., Twomey P.A.et al. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab. 81:1996;411-420.
9. Mazzucchelli R., Montironi R., Santinelli A.et al. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients. Prostate. 45:2000;72-79.
10. Semenza G.L. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54:2003;17-28.
11. Wartenberg M., Ling F.C., Muschen M.et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 17:2003;503-505.
12. Comerford K.M., Wallace T.J., Karhausen J.et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62:2002;3387-3394.
13. Zhong H., Chiles K., Feldser D.et al. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60:2000;1541-1545.
14. Zhong H., De Marzo A.M., Laughner E.et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835.
15. Zagzag D., Zhong H., Scalzitti J.M.et al. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer. 88:2000;2606-2618.
16. Singh V.N., Singh M., August J.T.et al. Alterations in glucose metabolism in chick-embryo cells transformed by Rous sarcoma virus: intracellular levels of glycolytic intermediates. Proc. Natl. Acad. Sci. USA. 71:1974;4129-4132.
17. Brand K.A., Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11:1997;388-395.
18. Bonkhoff H., Stein URemberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 24:1994;114-118.
19. McNeal J.E., Haillot O., Yemoto C. Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate. 27:1995;258-268.
20. Kelley M.R., Cheng L., Foster R.et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin. Cancer Res. 7:2001;824-830.
21. Huang L.E., Arany Z., Livingston D.M.et al. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271:1996;32253-32259.
22. Lando D., Pongratz I., Poellinger L.et al. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor. J. Biol. Chem. 275:2000;4618-4627.